42468-33-7

Basic information

• Product Name: 2,6-dichloro-4-mercaptophenol
• Synonyms: 2,6-dichloro-4-mercaptophenol
• CAS NO: 42468-33-7
• Molecular Formula: C₆H₄Cl₂OS
• Molecular Weight: 195.06636
• EINECS: 255-837-6
• Mol File: 42468-33-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 277.9°Cat760mmHg
• Flash Point: 121.9°C
• Appearance: /
• Density: 1.568g/cm³
• Vapor Pressure: 0.00261mmHg at 25°C
• Refractive Index: 1.663
• CAS DataBase Reference: 2,6-dichloro-4-mercaptophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-dichloro-4-mercaptophenol(42468-33-7)
• EPA Substance Registry System: 2,6-dichloro-4-mercaptophenol(42468-33-7)

Safety Data

• Hazardous Substances Data: 42468-33-7(Hazardous Substances Data)

Usage

General Description

2,6-dichloro-4-mercaptophenol, also known as DCP, is a chemical compound with the molecular formula C6H3Cl2SH. It is a yellowish crystalline solid with a distinct odor, and it is soluble in organic solvents. DCP is commonly used as a disinfectant and preservative in various industrial and agricultural applications, including water treatment, pulp and paper processing, and wood preservation. It is also employed as a pesticide and fungicide in the agricultural sector. DCP is known for its antimicrobial properties and is effective against a wide range of microorganisms, making it a valuable compound in the fields of public health and sanitation. However, it is important to handle DCP with care, as it can be toxic if ingested or inhaled, and may cause skin and eye irritation upon contact.

InChI:InChI=1/C6H4Cl2OS/c7-4-1-3(10)2-5(8)6(4)9/h1-2,9-10H

Upstream product

• 5930-28-9 4-amino-2,6-dichlorophenol 
• 14611-70-2 3,5-dichloro-4-hydroxyphenyl thiocyanate 

Downstream Products

• 105876-07-1 1-[3-[[3,5-dichloro-4-hydroxyphenyl]thio]-1-oxopropyl]-4-(phenylmethyl)piperazine 

Relevant articles and documents

Acylaminoalkylpyridineamides as inhibitors of metastasis

The present invention relates to a method of inhibiting tumor metastasis in an aminal by administering to an animal in need of such treatment an acrylaminoalkylpryridineamides represented by the formula STR1 wherein: R1 and R2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a STR2 group wherein n, m and p are independently an integer of from 1 to 8 provided n+m+p is equal to or less than 10; x is thio or sulfinyl; Alk1 is straight or branched chain lower alkylene of 1 to 6 carbon atoms, R3 is hydrogen or lower alkyl, Alk2 is straight or branched chain alkylene of 1 to 4 carbon atoms; R4 is selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl and lower alkoxy; or a pharmaceutically acceptable salt thereof, in an amount effective to inhibit tumor metastasis.

Method of treating inflammation, allergy, asthma and proliferative skin disease using heterocyclic amides

The compounds of this invention are heterocyclic amides represented by the formula: STR1 wherein: R1 R2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a STR2 group wherein q, r and t are independently an integer of from 1 to 8 provided that q+r+t is equal to or less than 10; y is thio, sulfinyl or sulfonyl; Alk is straight or branched chain lower alkylene, and R3 is a heterocyclic amine represented by the formula: STR3 wherein R4 is selected from the group consisting of hydrogen, lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, carboxyl or carboxyloweralkyl; X is selected from the group consisting of N--R4, O and CH2 ; m is 2 or 3; n is 2 or 3 when X is O or N--R4, and n is 1 to 3 when x is CH2 ; p is 0 to 2; and the pharmaceutically acceptable salts thereof. The compounds are anti-inflammatory and anti-allergy agents.

Acylaminoalkylpyridines ad use in treatment of inflammation and allergy reactions

The compounds of this invention are acylaminoalkylpyridines representd by the formula STR1 wherein: R1 and R2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a STR2 group wherein n, m and p are independently an integer of from 1 to 8 provided n+m+p is equal to or less than 10; X is thio, sulfinyl or sulfonyl; Alk1 is straight or branched chain lower alkylene of 1 to 6 carbon atoms, R3 is lower alkyl, Alk2 is straight or branched chain alkylene of 1 to 4 carbon atoms; R4 is selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl and lower alkoxy; and the pharmaceutically acceptable salts thereof. The compounds of the present invention are useful in the treatment of inflammation, allergy and hypersensitivity reactions and other disorders of the immune system.